XML 91 R57.htm IDEA: XBRL DOCUMENT v3.5.0.2
Acquisitions (Schedule of Estimated Fair Values of the Assets Acquired and Liabilities Assumed) (Details) - USD ($)
$ in Millions
 12 Months Ended
Jun. 30, 2016
Oct. 02, 2015
Aug. 26, 2015
Jul. 02, 2015
Jun. 30, 2015
Jun. 30, 2014
Business Acquisition [Line Items]            
Goodwill $ 7,167       $ 5,070 $ 4,878
Customer relationships | Minimum            
Business Acquisition [Line Items]            
Weighted average used lives of intangibles 4 years          
Customer relationships | Maximum            
Business Acquisition [Line Items]            
Weighted average used lives of intangibles 13 years          
Trade names | Minimum            
Business Acquisition [Line Items]            
Weighted average used lives of intangibles 10 years          
Trade names | Maximum            
Business Acquisition [Line Items]            
Weighted average used lives of intangibles 17 years          
Developed technology            
Business Acquisition [Line Items]            
Weighted average used lives of intangibles 10 years          
Cordis            
Business Acquisition [Line Items]            
Total identifiable intangible assets acquired   $ 800        
Cash and equivalents   0        
Trade receivables   0        
Inventories   207        
Prepaid expenses and other   4        
Property and equipment   97        
Other assets   20        
Accounts payable   (93)        
Other accrued liabilities   (16)        
Deferred income taxes and other liabilities   (7)        
Redeemable noncontrolling interests   0        
Total identifiable net assets/(liabilities) acquired   1,012        
Goodwill   861        
Total net assets acquired   1,873        
Cordis | In-process research and development            
Business Acquisition [Line Items]            
Indefinite-lived intangible assets   55        
Cordis | Customer relationships            
Business Acquisition [Line Items]            
Finite-lived intangible assets   225        
Cordis | Trade names            
Business Acquisition [Line Items]            
Finite-lived intangible assets   125        
Cordis | Developed technology            
Business Acquisition [Line Items]            
Finite-lived intangible assets   $ 395        
naviHealth            
Business Acquisition [Line Items]            
Total identifiable intangible assets acquired     $ 115      
Cash and equivalents     53      
Trade receivables     38      
Inventories     0      
Prepaid expenses and other     14      
Property and equipment     5      
Other assets     1      
Accounts payable     (2)      
Other accrued liabilities     (95)      
Deferred income taxes and other liabilities     (48)      
Redeemable noncontrolling interests     (119)      
Total identifiable net assets/(liabilities) acquired     (38)      
Goodwill     329      
Total net assets acquired     291      
naviHealth | In-process research and development            
Business Acquisition [Line Items]            
Indefinite-lived intangible assets     0      
naviHealth | Customer relationships            
Business Acquisition [Line Items]            
Finite-lived intangible assets     38      
naviHealth | Trade names            
Business Acquisition [Line Items]            
Finite-lived intangible assets     16      
naviHealth | Developed technology            
Business Acquisition [Line Items]            
Finite-lived intangible assets     $ 61      
Harvard Drug            
Business Acquisition [Line Items]            
Total identifiable intangible assets acquired       $ 600    
Cash and equivalents       44    
Trade receivables       67    
Inventories       49    
Prepaid expenses and other       11    
Property and equipment       16    
Other assets       0    
Accounts payable       (47)    
Other accrued liabilities       (37)    
Deferred income taxes and other liabilities       (188)    
Redeemable noncontrolling interests       0    
Total identifiable net assets/(liabilities) acquired       515    
Goodwill       634    
Total net assets acquired       1,149    
Harvard Drug | In-process research and development            
Business Acquisition [Line Items]            
Indefinite-lived intangible assets       0    
Harvard Drug | Customer relationships            
Business Acquisition [Line Items]            
Finite-lived intangible assets       470    
Harvard Drug | Trade names            
Business Acquisition [Line Items]            
Finite-lived intangible assets       130    
Harvard Drug | Developed technology            
Business Acquisition [Line Items]            
Finite-lived intangible assets       $ 0